CRY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.006200E-01
Normal-vs-Stage2
5.533400E-01
Normal-vs-Stage3
2.104600E-01
Normal-vs-Stage4
8.562400E-01
Stage1-vs-Stage2
1.828590E-01
Stage1-vs-Stage3
1.543620E-01
Stage1-vs-Stage4
6.335800E-01
Stage2-vs-Stage3
3.703400E-01
Stage2-vs-Stage4
6.718800E-01
Stage3-vs-Stage4
2.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.177000E-01
Normal-vs-AfricanAmerican
6.327800E-01
Normal-vs-Asian
2.438600E-01
Caucasian-vs-AfricanAmerican
3.294200E-01
Caucasian-vs-Asian
2.309200E-01
AfricanAmerican-vs-Asian
2.292400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.856000E-01
Normal-vs-Female
4.433000E-01
Male-vs-Female
5.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.448600E-01
Normal-vs-Age(41-60Yrs)
9.948200E-01
Normal-vs-Age(61-80Yrs)
3.719000E-01
Normal-vs-Age(81-100Yrs)
2.215800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.100200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.601420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.764000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.112410E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.274200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.621600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.828800E-01
Normal-vs-Daily Drinker
3.198800E-01
Normal-vs-Weekly Drinker
3.893200E-01
Normal-vs-Occasional Drinker
3.547200E-01
Normal-vs-Social Drinker
5.968600E-01
Non Drinker-vs-Daily Drinker
7.807400E-01
Non Drinker-vs-Weekly Drinker
7.736000E-01
Non Drinker-vs-Occasional Drinker
7.820800E-01
Non Drinker-vs-Social Drinker
3.744000E-01
Daily Drinker-vs-Weekly Drinker
6.442400E-01
Daily Drinker-vs-Occasional Drinker
6.344600E-01
Daily Drinker-vs-Social Drinker
3.360200E-01
Weekly Drinker-vs-Occasional Drinker
9.739600E-01
Weekly Drinker-vs-Social Drinker
6.100200E-01
Occasional Drinker-vs-Social Drinker
5.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.434600E-01
Normal-vs-Grade 2
2.733200E-01
Normal-vs-Grade 3
3.787600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.217780E-01
Grade 1-vs-Grade 3
5.679600E-02
Grade 1-vs-Grade 4
3.434600E-01
Grade 2-vs-Grade 3
3.551600E-01
Grade 2-vs-Grade 4
2.733200E-01
Grade 3-vs-Grade 4
3.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.302800E-01
Normal-vs-NonDiabetic
3.892600E-01
Diabetic-vs-NonDiabetic
7.839800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.059790E-01
Normal-vs-NoPancreatitis
4.132600E-01
Pancreatitis-vs-NoPancreatitis
1.548640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.531000E-01
Normal-vs-N1
6.293600E-01
N0-vs-N1
3.778800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.424400E-01
Normal-vs-TP53-NonMutant
8.970200E-01
TP53-Mutant-vs-TP53-NonMutant
1.193630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
